Polymyalgia rheumatica is characterised by pain and stiffness of neck muscles, shoulder and pelvic girdles that is worse in the morning, generally accompanied by constitutional symptoms and an elevated erythrocyte sedimentation rate. Abnormal liver function is uncommonly associated with polymyalgia rheumatica. We describe a case of an elderly lady with polymyalgia rheumatica who presented with a history of early morning stiffness and pain in the lower limbs and markedly deranged liver function. She responded remarkably well to corticosteroid therapy with rapid improvement in her symptoms and normalisation of her liver function test.
INTRODUCTION
Polymyalgia rheumatica is a chronic, inflammatory disorder of unknown cause. It usually affects people above 50 years of age and manifests as pain and morning stiffness of the neck, shoulders, hips, upper arms, and thighs 1 . Diagnosis is made on clinical grounds and confirmed by raised inflammatory markers, namely elevated erythrocyte sedimentation rate. Hepatocellular disease has been uncommonly associated with polymyalgia rheumatica 2 . The authors describe a patient with polymyalgia rheumatica who had abnormal liver function test.
CASE REPORT
A 77-year old lady with no past medical history presented with a three-week history of proximal stiffness and pain in bilateral lower limbs, resulting in inability to stand up from a sitting position. She also had occasional low-grade temperature without any other constitutional symptoms.
On examination, motor power was limited by pain in flexion, extension, abduction, adduction, internal and external rotation of the hips. Movement of knees, ankles and shoulders, elbows and wrists were preserved with full power. There was no acute joint inflammation, effusion or rash. Perianal sensation and anal tone were intact. Abdominal examination revealed mild right hypochondrial tenderness, but there was otherwise no organomegaly, stigmata of chronic liver disease or signs of hepatic decompensation.
The full blood count was unremarkable with normal white cell count. Of note, the erythrocyte sedimentation rate was significantly elevated at 120 mm/hr [normal range: 3-20 mm/hr]. Serum creatine phosphokinase (CK) was normal.
Liver function test revealed elevated transaminases more than three times upper limit, which subsequently normalised with corticosteroid therapy ( Table 1 ). Viral hepatitis markers (Hepatitis A IgM, Hepatitis C IgG, Hepatitis B surface antigen and Anti-HepB core IgM antibody) and HIV screen were non-reactive. Autoimmune screen (anti-dsDNA antibody, Anti-nuclear antibody, anti-neutrophil cytoplasmic antibodies, anti-liver/ kidney microsomal antibody, anti-smooth muscle antibody) was also normal. Coagulation profile was normal. In view of elevated transaminases, an ultrasound of the abdomen performed showed simple hepatic cysts. On further questioning, the Magnetic resonance imaging of the thoracolumbar spine and nerve conduction study of the lower limbs were normal.
Based on the clinical presentation and the elevated erythrocyte sedimentation rate, a diagnosis of polymyalgia rheumatica was made. The patient was started on oral corticosteroid therapy (prednisolone 20 mg once daily), with prompt resolution of pain and stiffness of the pelvic girdle and lower limb muscles. She also returned to her pre-morbid ambulatory state.
The patient was discharged, and followed up outpatient. She remained well, and liver function test normalised at four weeks after commencement of corticosteroid therapy. There was also improvement in the erythrocyte sedimentation rate from 120 mm/ hr to 64 mm/hr.
DISCUSSION
The diagnosis of polymyalgia rheumatica is usually made on clinical grounds, when patients present with morning stiffness or hip pain, accompanied by elevated erythrocyte sedimentation rate. Recently, the European League against Rheumatism and American College of Rheumatology proposed provisional criteria incorporating clinical and ultrasound criteria for the identification of polymyalgia rheumatica; this still requires further validation 3 . Management of polymyalgia rheumatica would involve starting low-dose corticosteroid 1 . Response is dramatic and duration of treatment is usually two years. Corticosteroid-sparing agents namely methotrexate and azathioprine are sometimes considered to reduce corticosteroidrelated adverse effects.
Hepatic involvement in polymyalgia rheumatica is a recognized but uncommon association. Serum alkaline phosphatase appears to be the most consistently elevated enzyme in 18 to 62% of patients with polymyalgia rheumatic 4, 5 . Elevated alanine and aspartate transaminases occur in 18% of patients with polymyalgia rheumatica 5 . Serum bilirubin is typically normal 4 . Histology of liver biopsy is usually normal, although hepatocytes necrosis with accompanying portal and lobular inflammation has been reported 4 . Imaging of the liver may sometimes reveal granulomas or cavernous hemangiomas 6, 7 . The pathogenesis of elevated transaminases in polymyalgia rheumatica remains unclear, but is postulated to be related to the deposition of circulating immune complexes in the branches of hepatic artery 4 . Other laboratory abnormalities in polymyalgia rheumatica include anaemia, leukocytosis and elevated inflammatory markers 1, 8 .
In our patient, the elevated liver enzymes are likely associated with polymyalgia rheumatica, rather than a second coincidental liver disease. She did not consume alcohol and was not on any drugs. There were no prodromal symptoms to suggest a viral etiology. Laboratory markers for both viral and autoimmune hepatitis were all normal. A normal level of CK excluded myositis as the cause of the transaminitis. Furthermore, the liver enzymes normalised with the commencement of treatment for polymyalgia rheumatica. Our patient had declined a liver biopsy which could have definitively excluded other causes of hepatocellular injury such as vasculitis.
In conclusion, polymyalgia rheumatica is a clinical diagnosis, and physicians should be aware of its association with elevated liver enzymes. Treatment of underlying condition with corticosteriods will result in rapid resolution of symptoms, and normalisation of liver function test.
